Those suffering from psoriasis are known to be at increased risk of cardiovascular disease like heart attack and stroke. A new treatment for psoriasis may also significantly decrease the cardiovascular risk.
In the treatment, a compound known as adalimumab (sold as Humira) is injected under the skin. The findings were presented at the annual meeting of the American Academy of Dermatology and showed that the treatment decreased skin damage and improved cardiovascular...